Your browser doesn't support javascript.
COVID-19 pandemic and inflammatory bowel disease from patients' perspective: A survey from COVID epicenter in India.
Kale, Aditya; Shinde, Leela; Sundaram, Sridhar; Patra, Biswa R; Rao, Praveen K; Irtaza, Mohd; Shukla, Akash.
  • Kale A; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
  • Shinde L; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
  • Sundaram S; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
  • Patra BR; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
  • Rao PK; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
  • Irtaza M; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
  • Shukla A; Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India.
JGH Open ; 6(2): 126-131, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1626036
ABSTRACT
BACKGROUND AND

AIM:

The COVID pandemic and countrywide lockdown has had significant impact on patients with inflammatory bowel disease (IBD), with delay in diagnosis, difficulty in access to healthcare and unavailability of drugs. We conducted a telephonic survey to assess this impact.

METHODS:

Out of 350, 302 participated in the survey. Demographic data, disease severity at the time of survey, extent of disease, details of therapy, and adherence were noted. A validated questionnaire addressing information source, perception of COVID-19 situation, contact with healthcare, and adherence to standard precautions was administered telephonically.

RESULTS:

Out of 350 contacted patients, 302 (86.28%) patients participated in the survey. Median age of cohort was 39 years. Ulcerative colitis (UC) constituted 79%, 16% Crohn's disease (CD), and 5% IBD-unclassified. At the time of survey, 86.98% patients with UC were in clinical remission and 75.75% of CD patients were generally well. A total of 115 (38%) cases were nonadherent to therapy due to unavailability of medicines (66.38%), financial constraints (25.21%) and inability to reach healthcare facility (3.6%). Disease flare was seen in 14.2% and correlated well with nonadherence. Existing drug therapy was switched to alternative drug in 70 (23.17%) cases due to unavailability (74%). Social media (52.3%) and television (40.4%) were the common sources of information about the pandemic. Telemedicine platforms (WhatsApp and telephone) were used by 180 (59.6%) patients for consultation with good acceptance (81.6%). 87 (28.8%) patients failed to contact healthcare. Apprehension regarding severe COVID infection was noted in 80% while 29% thought that IBD therapy could increase infection risk. Adherence to wearing mask, hand washing, and social distancing was 100%.

CONCLUSION:

Pandemic resulted in disruption of healthcare visits and medication supply. Majority were concerned about increased risk of COVID-19 infection and adhered to standard precautions. Mobile phone-based formats for patient care may be an alternative due to patient acceptance and convenience.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: JGH Open Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: JGH Open Year: 2022 Document Type: Article